Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://endpts.com/mustang-bio-to-lay-off-workers-maats-new-data-for-microbiome-therapy/
https://www.globenewswire.com/news-release/2024/03/28/2854074/0/en/Mustang-Bio-Announces-Vision-for-CAR-T-Cell-Therapy-Platform-Expansion-into-Autoimmune-Diseases.html
https://www.fiercebiotech.com/research/mustang-bio-and-city-hope-car-t-therapy-glioblastoma-extends-survival-phase-1-trial
https://www.globenewswire.com//news-release/2024/03/11/2844140/0/en/Mustang-Bio-Reports-Full-Year-2023-Financial-Results-and-Recent-Corporate-Highlights.html
https://www.globenewswire.com//news-release/2024/03/07/2842161/0/en/Mustang-Bio-Announces-Publication-in-Nature-Medicine-of-Data-from-Phase-1-Trial-Evaluating-MB-101-IL13R%CE%B12-targeted-CAR-T-Cells-in-High-Grade-Glioma.html
https://www.globenewswire.com//news-release/2024/01/11/2807933/0/en/Mustang-Bio-to-Participate-in-the-B-Riley-Securities-4th-Annual-Oncology-Conference.html
https://www.globenewswire.com//news-release/2023/12/11/2793874/0/en/Mustang-Bio-Presents-Updated-Phase-1-2-Multicenter-Clinical-Data-for-MB-106-at-the-2023-American-Society-of-Hematology-ASH-Annual-Meeting.html
https://www.globenewswire.com//news-release/2023/11/14/2780523/0/en/Mustang-Bio-Reports-Third-Quarter-2023-Financial-Results-and-Recent-Corporate-Highlights.html
https://www.globenewswire.com//news-release/2023/11/02/2772473/0/en/Mustang-Bio-Announces-MB-106-CD20-Targeted-CAR-T-Data-Selected-for-Presentation-at-65th-American-Society-of-Hematology-ASH-Annual-Meeting.html
https://www.globenewswire.com//news-release/2023/10/30/2769605/0/en/Mustang-Bio-Announces-Closing-of-4-4-Million-Registered-Direct-Offering-Priced-At-the-Market-Under-Nasdaq-Rules.html